Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
348 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (3)

Medical Condition

  • Show all (226)
  • Addiction (1)
  • Allergy, Asthma, & Immunology (3)
  • Autoimmune Disorders (4)
  • Cancer (160)
    • Breast Cancer (3)
    • Gynecologic Cancer (1)
    • Head and Neck Cancer (1)
    • Leukemia (1)
    • Lung Cancer (62)
    • Pancreatic Cancer (1)
    • (-) Prostate Cancer (1)
    • Skin Cancer (3)
    • Solid Tumors (10)
    • Uveal Melanoma (1)
  • COVID-19 (Coronavirus) (3)
  • Healthy Volunteers (8)
  • Heart Disease (4)
  • (-) Liver Disease (2)
    • Hepatitis (1)
  • Lung Disease (32)
  • Neurological Disorders (1)
  • Pediatrics (5)
  • Surgery (1)
  • Transplant (2)
Displaying 1 - 3 of 3

A study for patients with chronic hepatitis C and advanced heart failure or lung disease using study drug Harvoni

Condition: Liver Disease / Hepatitis
Investigator: Elizabeth Verna, MD
Status: Closed
This research trial is being conducted to determine the safety and efficacy of HARVONI (an FDA-approved Hepatitis C Virus medication) in HCV (genotype 1, 4, 5, an 6) infected patients who also have advanced heart failure or chronic lung disease. HARVONI has not been tested in patients with HCV and heart failure or chronic…
Read More

Study of Abiraterone Acetate, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Condition: Cancer / Prostate Cancer
Investigator: Mark Stein, MD
Status: Closed
The purpose of this study is to find out whether delivering SBRT to the prostate, combined with the study drug atezolizumab, is a safe and effective treatment when given in combination with abiraterone, prednisone, and Lupron (the standard treatment for this disease). In addition, the researchers want to find out whether the study treatment works better…
Read More

Study for patients with Hepatopulmonary syndrome (SHPS) using trial drug (Sorafenib)

Condition: Liver Disease
Investigator: Robert Brown, MD, MPH
Status: Closed
The purpose of this study is to determine the safety and effects of a drug, sorafenib in adults diagnosed with hepatopulmonary syndrome (HPS). The study will evaluate how well the drug is tolerated and its effect on the level of oxygen in the blood and the function of the lung vessels. Participants will be randomly assigned to…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science